Addus HomeCare Co. (NASDAQ:ADUS) Holdings Cut by Kennedy Capital Management LLC

Kennedy Capital Management LLC lowered its holdings in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 23.2% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 80,703 shares of the company’s stock after selling 24,352 shares during the period. Kennedy Capital Management LLC owned approximately 0.49% of Addus HomeCare worth $8,340,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently modified their holdings of the company. Lord Abbett & CO. LLC acquired a new position in Addus HomeCare in the 1st quarter valued at approximately $8,274,000. Allianz Asset Management GmbH bought a new stake in Addus HomeCare in the fourth quarter worth $5,667,000. Vanguard Group Inc. boosted its holdings in Addus HomeCare by 4.9% in the third quarter. Vanguard Group Inc. now owns 1,218,564 shares of the company’s stock worth $103,809,000 after purchasing an additional 57,040 shares in the last quarter. Assenagon Asset Management S.A. increased its position in Addus HomeCare by 78.8% during the first quarter. Assenagon Asset Management S.A. now owns 112,256 shares of the company’s stock worth $11,601,000 after buying an additional 49,483 shares during the last quarter. Finally, TimesSquare Capital Management LLC raised its holdings in Addus HomeCare by 13.0% during the fourth quarter. TimesSquare Capital Management LLC now owns 264,088 shares of the company’s stock valued at $24,521,000 after buying an additional 30,330 shares in the last quarter. Institutional investors and hedge funds own 95.35% of the company’s stock.

Insider Transactions at Addus HomeCare

In other Addus HomeCare news, EVP Roberton James Stevenson sold 217 shares of the firm’s stock in a transaction on Monday, June 17th. The stock was sold at an average price of $116.13, for a total transaction of $25,200.21. Following the transaction, the executive vice president now owns 10,217 shares in the company, valued at approximately $1,186,500.21. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Insiders own 4.60% of the company’s stock.

Addus HomeCare Stock Down 0.7 %

Shares of NASDAQ:ADUS traded down $0.85 during mid-day trading on Wednesday, reaching $120.62. 3,698 shares of the stock were exchanged, compared to its average volume of 134,392. The company has a market cap of $2.18 billion, a P/E ratio of 30.14, a P/E/G ratio of 2.37 and a beta of 1.01. Addus HomeCare Co. has a one year low of $78.35 and a one year high of $125.24. The stock’s 50 day simple moving average is $117.40 and its 200-day simple moving average is $104.18. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.14.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings results on Monday, May 6th. The company reported $1.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.97 by $0.24. Addus HomeCare had a return on equity of 10.03% and a net margin of 6.04%. The business had revenue of $280.70 million during the quarter, compared to the consensus estimate of $279.49 million. During the same quarter last year, the firm posted $0.84 EPS. The company’s quarterly revenue was up 11.6% on a year-over-year basis. As a group, equities research analysts predict that Addus HomeCare Co. will post 4.36 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on the company. TD Cowen raised their price objective on Addus HomeCare from $119.00 to $128.00 and gave the company a “buy” rating in a research note on Tuesday, June 18th. Bank of America upped their price target on shares of Addus HomeCare from $115.00 to $118.00 and gave the company a “buy” rating in a report on Tuesday, May 7th. Stephens increased their target price on Addus HomeCare from $120.00 to $128.00 and gave the company an “overweight” rating in a research note on Friday, May 31st. StockNews.com lowered Addus HomeCare from a “strong-buy” rating to a “buy” rating in a report on Sunday, July 7th. Finally, Oppenheimer raised their price objective on shares of Addus HomeCare from $118.00 to $130.00 and gave the stock an “outperform” rating in a research note on Friday, June 7th. One equities research analyst has rated the stock with a sell rating and nine have given a buy rating to the company. Based on data from MarketBeat.com, Addus HomeCare currently has an average rating of “Moderate Buy” and a consensus target price of $116.25.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.